Physiologically‐Based Kinetic Modeling of Intravenously Administered Gold (Au) Nanoparticles
Abstract: Physiologically‐based kinetic (PBK) modeling is a valuable tool to understand the kinetics of nanoparticles (NPs) in vivo. However, estimating PBK parameters remains challenging and commonly requires animal studies. To develop predictive models to estimate PBK parameter values based on NP characteristics, a database containing PBK parameter values and corresponding NP characteristics is needed. As a first step toward this objective, this study estimates PBK parameters for gold NPs (AuNPs) and provides a comparison of two different NPs. Two animal experiments are conducted in which varying doses of AuNPs attached with polyethylene glycol (PEG) are administered intravenously to rats. The resulting Au concentrations are used to estimate PBK model parameters. The parameters are compared with PBK parameters previously estimated for poly (alkyl cyanoacrylate) NPs loaded with cabazitaxel and for LipImage 815. This study shows that a small initial database of PBK parameters collected for three NPs is already sufficient to formulate new hypotheses on NP characteristics that may be predictive of PBK parameter values. Further research should focus on developing a larger database and on developing quantitative models to predict PBK parameter values.
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Physiologically‐Based Kinetic Modeling of Intravenously Administered Gold (Au) Nanoparticles ; day:24 ; month:02 ; year:2023 ; extent:10
Small ; (24.02.2023) (gesamt 10)
- Creator
-
Minnema, Jordi
Vandebriel, Rob J.
Boer, Karin
Klerx, Walther
De Jong, Wim H.
Delmaar, Christiaan J. E.
- DOI
-
10.1002/smll.202207326
- URN
-
urn:nbn:de:101:1-2023022814041754894280
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Minnema, Jordi
- Vandebriel, Rob J.
- Boer, Karin
- Klerx, Walther
- De Jong, Wim H.
- Delmaar, Christiaan J. E.
Other Objects (12)
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Physiologically based kinetic modeling of the bioactivation of myristicin
Use of physiologically based kinetic modeling to predict neurotoxicity and genotoxicity of methylglyoxal in humans
Orally administered nanoparticles for gastrointestinal applications
Monocrotaline-induced liver toxicity in rat predicted by a combined in vitro physiologically based kinetic modeling approach
Study on inter-ethnic human differences in bioactivation and detoxification of estragole using physiologically based kinetic modeling
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Population physiologically-based pharmacokinetic model incorporating lymphatic uptake for a subcutaneously administered pegylated peptide
Integrating in vitro data and physiologically based kinetic modeling-facilitated reverse dosimetry to predict human cardiotoxicity of methadone
From hazard to risk prioritization: a case study to predict drug-induced cholestasis using physiologically based kinetic modeling
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Physiologically based kinetic modeling of the bioactivation of myristicin
Use of physiologically based kinetic modeling to predict neurotoxicity and genotoxicity of methylglyoxal in humans
Orally administered nanoparticles for gastrointestinal applications
Monocrotaline-induced liver toxicity in rat predicted by a combined in vitro physiologically based kinetic modeling approach
Study on inter-ethnic human differences in bioactivation and detoxification of estragole using physiologically based kinetic modeling
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Population physiologically-based pharmacokinetic model incorporating lymphatic uptake for a subcutaneously administered pegylated peptide
Integrating in vitro data and physiologically based kinetic modeling-facilitated reverse dosimetry to predict human cardiotoxicity of methadone
From hazard to risk prioritization: a case study to predict drug-induced cholestasis using physiologically based kinetic modeling
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Physiologically based kinetic modeling of the bioactivation of myristicin
Use of physiologically based kinetic modeling to predict neurotoxicity and genotoxicity of methylglyoxal in humans
Orally administered nanoparticles for gastrointestinal applications
Monocrotaline-induced liver toxicity in rat predicted by a combined in vitro physiologically based kinetic modeling approach
Study on inter-ethnic human differences in bioactivation and detoxification of estragole using physiologically based kinetic modeling
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Population physiologically-based pharmacokinetic model incorporating lymphatic uptake for a subcutaneously administered pegylated peptide
Integrating in vitro data and physiologically based kinetic modeling-facilitated reverse dosimetry to predict human cardiotoxicity of methadone
From hazard to risk prioritization: a case study to predict drug-induced cholestasis using physiologically based kinetic modeling
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations